FDA Investigator Steven A Brettler

Steven A Brettler has conducted inspections on 22 sites in 3 countries as of 03 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
22
Last Inspection Date:
03 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
100009085
Countries of Inspections:
China, United States of America, India
FDA Investigators that have inspected at least one site in common with Steven A Brettler:
Aaron J Fox, Adam R Cooke, Alantis N Griffin, Albert A Salvador, Alice S Tsao, Angela E Glenn, Anita Narula, PhD, Ariel Cruz Figueroa, Bichsa T Tran, Bijoy Panicker, Bill Tacket, Jr, Blondell W Johnson, Brandon C Heitmeier, Brittny C Cargo, Camerson E Moore, CDR Ileana Barreto Pettit, Charles D Brown, Cheryl A Clausen, Christie A Soto, Christos G Tsingelis, Clifton C Francis, Clinton J Lott, Courtney A Gilbert, Cynthia R Gibson, Damaris Y Hernandez, Daryl A Dewoskin, David P King, Dawn E Barkans, Dawn M Mccabe, Deborah A Greco, Dillard H Woody, Jr, Dipti Kalra, Djamila Harouaka, Dusty F Snoeberg, Edward H Maticka, Edwin Martinez, Felix Maldonado, Francis A Guidry, Gam S Zamil, Gene R Gunn, Gina Eng, Gwyn G Dickinson, Haley H Seymour, Harshal J Desai, Ivis L Negron, James C Maclaughlin, James S Cartwright, Jamie L Port, Jared P Stevens, Jason F Chancey, Jennifer A Robinson, Jennifer L Huntington, Jennifer Lalama, Jessica L Pressley, Joanne E King, Joel D Hustedt, Jogy George, Jose A Lopez, José E Meléndez, Jose Velez, June P Page, Justin A Boyd, Justin N Henson, Karl D Hezel, Kelly I Anderson, Kham Phommachanh, Ladislav Kermet, Lareese K Thomas, Larry K Austin, Lata C Mathew, PhD, Laura L Staples, LCDR Michael H Tollon, Libia M Lugo, Llopis, LT Daveta L Bailey, LT Kimberly M Hull, LT Richard A Lyght, Lundy H Patrick, Mahaffey, Marc Balzarini, Marinee Flores Marrero, Matthew B Thomaston, Melanie G Warzala, Melanie W Pishnery, Michael R Goga, Michelle S Dunaway, Miguel A Martinez Perez, Mihaly S Ligmond, Mizanne E Lewis, Muralidhara B Gavini, PhD, Nicolas Riveratorres, Nicole E Knowlton, Noreen Muñiz, Patty P Kaewussdangkul, Paul L Figarole, Jr, Pratik S Upadhyay, DDC, Rachael L Cook, Rebecca Rodriguez, Regan T Harp, Rodney W Lenger, Ross J Grigsby, Rozelle G Smith, Saleem A Akhtar, Salvatore N Randazzo, Samantha J Pinizzotto, D V M, Santos E Camara, Sarah E Mcmullen, Saundrea A Munroe, Scott T Ballard, Seneca D Toms, Shavon L Square, Shelby N Turner, Sonia M Monges, Stephanie D Crockett, Stephen G Mclane, Steven D Dittert, Steven D Kehoe, Susan F Laska, MS, Susan M Turcovski, Tamara M Casselman, Tracy L Reed, Vincent Thomas, Walden H Lee, Youmin Wang, Zhao Wang, PhD, Zhaoyang Meng

Steven A Brettler's Documents

Publish Date Document Type Title
February, 2023 FDA 483 GADAL Laboratories, Inc - Form 483, 2023-02-17
July, 2021 FDA 483 Cross Brands Contract Filling - Form 483, 2021-07-19
October, 2023 FDA 483 Products by O2, Inc - Form 483, 2023-10-23
June, 2024 FDA 483 Torrent Pharmaceuticals Limited - Form 483, 2024-06-12
November, 2021 FDA 483 Belcher Pharmaceuticals, LLC - Form 483, 2021-11-15
April, 2023 FDA 483 Ion Labs Inc - Form 483, 2023-04-28
January, 2023 FDA 483 RWM TECHNOLOGIES LLC - Form 483, 2023-01-13
September, 2022 FDA 483 PAI Holdings, LLC, dba Pharmaceutical Associates, Inc - Form 483, 2022-09-02
January, 2024 FDA 483 Nexair, LLC - Form 483, 2024-01-12
September, 2023 FDA 483 Aveva Drug Delivery Systems Inc. - Form 483, 2023-09-01
August, 2022 FDA 483 Infusion Systems of SW Florida Inc. dba Myerlee Pharmacy - Form 483, 2022-08-11
April, 2023 FDA 483 Response Ion Labs Inc - Form 483R, 2023-04-28
February, 2024 FDA 483 Horizon Pharmaceuticals , Inc. - Form 483, 2024-02-16
March, 2022 EIR RadioMedix, Inc. - EIR, 2022-03-24
June, 2022 FDA 483 FARMAKEIO OUTSOURCING LLC - Form 483, 2022-06-14
March, 2022 FDA 483 RadioMedix, Inc. - Form 483, 2022-03-24
February, 2022 FDA 483 Davis City Pharmacy Inc. - Form 483, 2022-02-18
August, 2021 FDA 483 HILL DERMACEUTICALS, INC. - Form 483, 2021-08-11
July, 2021 FDA 483 Response Cross Brands Contract Filling - Form 483R, 2021-08-09
April, 2024 FDA 483 Strides Alathur Private Limited - Form 483, 2024-04-05
June, 2024 FDA 483 Mylan Laboratories Limited - Form 483, 2024-06-26
August, 2024 FDA 483 Purac America, Inc. - Form 483, 2024-08-02

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more